June / May 2021

Written By Daniel Quay

• Provided testimony to Food and Drug Administration Summit on Morphine Milligram Equivalents (MMEs).

• Presented Abstracts at the National Academy of Medicine Stigma of Addiction Conference. 

• Responded to the Agency for Healthcare Research and Quality (AHRQ) call for comment on its draft report on Integrated Pain Management Programs.

• Met with Department of Justice Civil Rights Division on issues involving access to care and services. 

• Met with White House Office of National Drug Control Policy (ONDCP).

Daniel Quay
Previous

July 2021
Next

April 2021